Talphera (TLPH) Change in Acquisitions & Divestments (2011 - 2026)
Talphera (TLPH) posted Change in Acquisitions & Divestments of $1.1 million for Q2 2026, down 92.4% on a QoQ basis from $14.5 million in Q1 2026.
Analysis
Talphera (TLPH) Change in Acquisitions & Divestments (2011 - 2026) Analysis & Trends
Talphera has reported Change in Acquisitions & Divestments for 15 years, with the latest figure at $1.1 million in Q2 2026.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $1.1 million in Q2 2026; TTM through Jun 2026 was $19.1 million, a 3081.5% increase from a year earlier, with the FY2025 full-year figure at $3.5 million, down 60.5% from the prior year.
- Change in Acquisitions & Divestments was $1.1 million for Q2 2026 at Talphera, down from $14.5 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $27.6 million in Q1 2022, with the low at $500000.0 in Q1 2023.
- Average Change in Acquisitions & Divestments over 5 years is $6.8 million, with a median of $3.5 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments soared 291.99% in 2022, then plunged 98.19% in 2023.
- Over 5 years, Change in Acquisitions & Divestments stood at $3.2 million in 2022, then slumped by 84.38% to $500000.0 in 2023, then advanced by 20.0% to $600000.0 in 2024, then surged by 476.67% to $3.5 million in 2025, then tumbled by 68.09% to $1.1 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $1.1 million (Q2 2026), $14.5 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 14.53 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 6.66 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 3.20 Mn |
| Sep 30, 2022 | 4.60 Mn |
| Jun 30, 2022 | 10.97 Mn |
| Mar 31, 2022 | 27.60 Mn |
| Dec 31, 2021 | 10.00 Mn |
| Sep 30, 2021 | 9.20 Mn |
| Jun 30, 2021 | 17.74 Mn |
| Mar 31, 2021 | 7.04 Mn |
| Dec 31, 2020 | 13.20 Mn |
| Sep 30, 2020 | 8.85 Mn |
| Jun 30, 2020 | 23.08 Mn |
| Mar 31, 2020 | 35.48 Mn |
| Dec 31, 2019 | 25.28 Mn |